scispace - formally typeset
Open Access

Angiogenesis in chronic obstructive pulmonary disease: a translational appraisal.

TLDR
A number of pro- and anti-angiogenic factors are presented, which can be also used as potential biomarkers to monitor disease progression and explore both basic and clinical research in this field.
Abstract
Angiogenesis is a crucial component of lung pathophysiology, not only in cancer but also in other disorders, such as chronic obstructive pulmonary disease (COPD). In COPD angiogenesis is definitely able to control and orchestrate the progression of airway remodeling. Herein, we provide several remarkable translational aspects of angiogenesis in COPD, exploring both basic and clinical research in this field. Indeed, we present a number of pro- and anti-angiogenic factors, which can be also used as potential biomarkers to monitor disease progression.

read more

Citations
More filters
Journal ArticleDOI

Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes

TL;DR: The major findings of research on ageing in several organs and tissues expressing βARs are summarized in a systematic way: heart, vessels, skeletal muscle, respiratory system, brain, immune system, pancreatic islets, liver, kidney and bone.
Book ChapterDOI

microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis

TL;DR: How microRNAs (miRs)--noncoding RNAs that can regulate gene expression via translational repression and/or post-transcriptional degradation--distinctively modulate EC and VSMC function in physiology and disease is described.
Journal ArticleDOI

VEGF and FGF-2: Promising targets for the treatment of respiratory disorders

TL;DR: VEGF and FGF-2 are the strongest activators of angiogenesis which stimulate migration and proliferation of endothelial cells in existing vessels to generate and stabilize new blood vessels and their role as anti-angiogenetic agents in lung disorders is highlighted.
Journal ArticleDOI

IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.

TL;DR: It is shown that IL-36γ has the potential to enhance endothelium directed leucocyte infiltration into the skin and strengthen the IL-23/IL-17 pathway adding to the growing evidence of pathogenetic roles for IL- 36γ in psoriatic responses.
Journal ArticleDOI

WNT receptor signalling in lung physiology and pathology

TL;DR: The diverse expression of various WNT receptors and co-receptors in the aforementioned chronic lung diseases are highlighted and the currently available biologicals and pharmacological tools to modify proximal WNT signalling are discussed.
References
More filters
Journal ArticleDOI

Toxicity and response criteria of the Eastern Cooperative Oncology Group

TL;DR: The Eastern Cooperative Oncology Group criteria for toxicity and response are presented to facilitate future reference and to encourage further standardization among those conducting clinical trials.
Journal ArticleDOI

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

TL;DR: The addition of bevacizumab to paclitaxel plus carboplatin in the treatment of selected patients with non-small-cell lung cancer has a significant survival benefit with the risk of increased treatment-related deaths.
Journal ArticleDOI

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

TL;DR: Tumor ascites fluids from guinea pigs, hamsters, and mice contain activity that rapidly increases microvascular permeability, and this activity is secreted by these tumor cells and a variety of other tumor cell lines in vitro.
Journal ArticleDOI

Basic and Therapeutic Aspects of Angiogenesis

TL;DR: The emerging principles of vascular growth provide exciting new perspectives, the translation of which might overcome the current limitations of pro- and antiangiogenic medicine.
Related Papers (5)
Trending Questions (1)
What can we be adding to our diets that's naturally angiogenic?

Indeed, we present a number of pro- and anti-angiogenic factors, which can be also used as potential biomarkers to monitor disease progression.